| 000 | 01755 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517134731.0 | ||
| 264 | 0 | _c20170503 | |
| 008 | 201705s 0 0 eng d | ||
| 022 | _a1179-6901 | ||
| 024 | 7 |
_a10.1007/s40268-017-0174-z _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMata-Marín, José Antonio | |
| 245 | 0 | 0 |
_aEffectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients. _h[electronic resource] |
| 260 |
_bDrugs in R&D _cMar 2017 |
||
| 300 |
_a225-231 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRaltegravir Potassium _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSmeke, Ariane Estrella Weiser | |
| 700 | 1 | _aRodriguez, Mariana Rotzinger | |
| 700 | 1 | _aChávez-García, Marcelino | |
| 700 | 1 | _aBanda-Lara, Marco Isaac | |
| 700 | 1 | _aRios, Alma Minerva Pérez | |
| 700 | 1 | _aNuñez-Rodríguez, Nohemí | |
| 700 | 1 | _aDomínguez-Hermosillo, Juan Carlos | |
| 700 | 1 | _aSánchez, Alberto Chaparro | |
| 700 | 1 | _aJuarez-Kasusky, Irene | |
| 700 | 1 | _aHerrera, Javier Enrique Cruz | |
| 700 | 1 | _aRamírez, Jorge Luis Sandoval | |
| 700 | 1 | _aGaytán-Martínez, Jesús | |
| 773 | 0 |
_tDrugs in R&D _gvol. 17 _gno. 1 _gp. 225-231 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40268-017-0174-z _zAvailable from publisher's website |
| 999 |
_c26819771 _d26819771 |
||